"Device landing zone" calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVI

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 3, 2010, Pages 431-439

  Latsios, George ^a   Gerckens, Ulrich ^a   Buellesfeld, Lutz ^a   Mueller, Ralf ^a   John, Daniel ^a   Yuecel, Seyrani ^a   Syring, Joerg ^a   Sauren, Barthel ^a   Grube, Eberhard ^a  

^a Heart Center Siegburg   (Germany)

Author keywords

Aortic valve stenosis; Calcification; Cardiac CT; Pacemaker implantation; Trans catheter aortic valve implantation

Indexed keywords

CALCIUM;

AGED; AORTA VALVE STENOSIS; AREA UNDER THE CURVE; ARTICLE; COMPUTER AIDED DESIGN; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; GENDER; HEART ASSIST DEVICE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PROSPECTIVE STUDY; PROSTHESIS; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SINUS NODE; SYMPTOM; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; ARRHYTHMIAS, CARDIAC; CALCINOSIS; CARDIAC PACING, ARTIFICIAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GERMANY; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; LOGISTIC MODELS; MALE; ODDS RATIO; PACEMAKER, ARTIFICIAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STROKE VOLUME; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77955651417     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22563     Document Type: Article

References (27)

1. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842-850.
2. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg first-in-man study. Circulation 2006;114:1616-1624. (Pubitemid 44547432)
3. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: Analysis of the EuroSCORE multinational database of 19.030 patients. Eur J Cardiothorac Surg 1999;15:816-822.
4. Vahanian A, Alfieri O, Al-Attar N, et al. European Association of Cardio-Thoracic Surgery; European Society of Cardiology; European Association of Percutaneous Cardiovascular Interventions. Transcatheter valve implantation for patients with AS: A position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008;29:1463-1470.
5. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe AS in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: Device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76.
6. Grube E, Buellesfeld L, Mueller R, et al. Progress and current status of percutaneous aortic valve replacement: Results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Intervent 2008;1:167-175.
7. Piazza N, Onuma Y, Jesserun E, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 2008;1:310-316. (Pubitemid 351804194)
8. Jilaihawi H, Chin D, Vasa-Nicotera M, et al. Predictors for permanent PM requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J 2009;157:860-866.
9. Richards KL, Cannon SR, Miller JF, Crawford MH. Calculation of aortic valve area by Doppler echocardiography: A direct application of the continuity equation. Circulation 1986;73:964-969.
10. Otto CM, Pearlman AS, Comess KA, Reamer RP, Janko CL, Huntsman LL. Determination of the stenotic aortic valve area in adults using Doppler echocardiography. J Am Coll Cardiol 1986;7:509-517.
11. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832.
12. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145-2161. (Pubitemid 35192824)
13. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroInterv 2008;4:242-249.
14. Piazza N, de Jaegere P, Schultz P, Becker A, Serruys PW, Anderson R. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Intervent 2008;1:74-81.
15. Piazza N, Onuma Y, Jesserun E, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 2008;1:310-316.
16. Dawkins S, Hobson AR, Kalra PR, et al. Permanent pacemaker implantation after isolated aortic valve replacement: Incidence, indications, and predictors. Ann Thorac Surg 2008;85:108-112. (Pubitemid 350284581)
17. Endogen HB, Kayalar N, Ardal H, et al. Risk factors for requirement of permanent pacemaker implantation after aortic valve replacement. J Card Surg 2006;21:211-215.
18. Habicht JM, Scherr P, Zerkowski HR, et al. Late conduction defects following aortic valve replacement. J Heart Valve Dis 2000;9:629-632.
19. Messika-Zeitoun D, Aubry MC, Detaint D, et al. Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography. Circulation 2004;110:356-362.
20. Woodring JH, West JW. CT of aortic and mitral valve calcification. J Ky Med Soc 1989;8:177-180.
21. Lippert JA, White CS, Mason AC, Plotnick GD. Calcification of aortic valve detected incidentally on CT scans: Prevalence and clinical significance. AJR 1995;164:73-77.
22. Davies SW, Gershlick AH, Balcon R. Progression of valvar AS: A long-term retrospective study. Eur Heart J 1991;12:10-14.
23. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic AS. N Engl J Med 2000;343:611-617.
24. Bahler RC, Desser DR, Finkelhor RS, Brener SJ, Youssefi M. Factors leading to progression of valvular AS. Am J Cardiol 1999;84:1044-1048.
25. Feuchtner GM, Muller S, Grander W, et al. Aortic valve calcification as quantified with multislice computed tomography predicts short-term clinical outcome in patients with asymptomatic AS. J Heart Valve Dis 2006;15:494-498.
26. Luciani GB, Casali G, Mazzucco A. Risk factors for coronary complications after stentless aortic root replacement. Semin Thorac Cardiovasc Surg 1999;11:126-132.
27. John D, Buellesfeld L, Yuecel S, et al. Correlation of aortic valve calcifications and acute procedural success in patients undergoing TAVI using the self-expanding CoreValve prosthesis. JACC Cardiovasc Interv 2010;3:233-243.